Sclerostin, an emerging therapeutic target for treating osteoporosis and osteoporotic fracture: A general review
Osteoporosis and its associated fracture risk has become one of the major health burdens in our aging population. Currently, bisphosphonate, one of the most popular antiresorptive drugs, is used widely to treat osteoporosis but so far still no consensus has been reached for its application in treatm...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2016-01-01
|
| Serija: | Journal of Orthopaedic Translation |
| Teme: | |
| Online pristup: | http://www.sciencedirect.com/science/article/pii/S2214031X15000613 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|